The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

JLL said VC investment in the Bay Area’s life sciences and technology research sectors is beginning to rebound, with $35.4 ...

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...

Life sciences and healthcare companies will have to focus on seeing consumers as more than patients, according to a recent ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices. Trum ...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome ...

We are benefitted by a hard-wired health care and science infrastructure — difficult to deconstruct — and it is functioning ...

As AI becomes more prevalent, organizations need to leverage the power of scope, scale, speed, and human-AI collaboration for ...

Roth MKM analyst Jason Wittes initiated coverage of TriSalus Life Sciences (TLSI) with a Buy rating and $11 price target The company’s ...